This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Manulife (MFC) Q4 Earnings Rise Y/Y on Solid Asia Business
by Zacks Equity Research
Manulife (MFC) Q4 results reflect new business growth in Asia, favorable of lower U.S. tax rates, improved policyholder experience and improved expense efficiency.
Manulife Financial (MFC) Q4 Earnings: Is a Beat in Store?
by Zacks Equity Research
Manulife's (MFC) Q4 earnings is likely to benefit from solid Asian operations, expansion of its wealth and asset management business and cost-savings initiatives.
Why Manulife (MFC) Could Beat Earnings Estimates Again
by Zacks Equity Research
Manulife (MFC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Investment Tips to Help You Achieve Your 2019 Goals
by Chandrima Sanyal
Here are a few ways to invest your money that will help you improve your financial health and mitigate the impacts of any potential adversity.
Zacks.com featured expert Kevin Matras highlights: Helmerich & Payne, Manulife Financial, HEICO, Amedisys and Titan Machinery
by Zacks Equity Research
Zacks.com featured expert Kevin Matras highlights: Helmerich & Payne, Manulife Financial, HEICO, Amedisys and Titan Machinery
Buy These 5 Low Leverage Stocks to Stay Away From Debt Traps
by Zacks Equity Research
Since debt-ridden companies are more vulnerable at times of crisis, it is better to avoid those. Of course, entirely avoiding companies with debt loads is virtually impossible.
Should Value Investors Buy Manulife Financial (MFC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why You Should Add Torchmark (TMK) Stock to Your Portfolio
by Zacks Equity Research
Torchmark (TMK) promises better reward for investors banking on operational excellence.
These 3 Insurance Losers of 2018 Could be Big Winners in 2019
by Zacks Equity Research
We zeroed on three insurers that stand a good chance of bouncing back next year after having taken a beating this year.
Is Manulife Financial (MFC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Buy These 5 Low Leverage Stocks for Steady Returns
by Zacks Equity Research
Since, companies bearing large amount of debts are more prone to financial crisis, the amount of debt a company bears plays a crucial role in an investment decision
Top Ranked Value Stocks to Buy for December 19th
by Zacks Equity Research
Here are three stocks with buy rank and strong value characteristics for investors to consider today, December 19th
5 Best Performing Life Insurance Stocks to Buy for 2019
by Zacks Equity Research
We zoom in on five life insurance picks with great prospects and wait to see if these can continue with the momentum in 2019.
5 Incredible ETFs & Stocks to Buy on the Dip
by Sweta Killa
The dips might charge up investors to snap up stocks and ETFs on the cheap for outsized gains heading into Christmas.
Manulife (MFC) Down 8.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Manulife (MFC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Buy These 5 Low Leverage Stocks to Counter Uncertainties
by Zacks Equity Research
A comparative analysis of the cost of capital theory reveals that most companies prefer debt financing over equity. However, companies with large debt loads are more vulnerable during economic downturns
Reinsurance Group (RGA) Rides on Steady Top-Line Improvement
by Zacks Equity Research
Product-line expansion, robust revenues, improved investment results and strong capital position aid Reinsurance Group (RGA) to surface as a prospective choice for yield-seeking investors.
Is Manulife Financial (MFC) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
American Equity's (AEL) Annuity Business Continues to Shine
by Zacks Equity Research
Solid annuity business, better investment results and capital strength aid American Equity (AEL) to emerge as a prospective choice for yield-seeking investors.
Torchmark (TMK) Continues to Benefit from Premium Growth
by Zacks Equity Research
Torchmark (TMK) continues to gain from premium growth and strong segmental performances.
Why You Should Add Manulife Financial (MFC) to Your Portfolio
by Zacks Equity Research
Manulife Financial (MFC) promises better reward for investors banking on operational excellence.
Manulife Financial (MFC): The Perfect Mix of Value and Rising Earnings Estimates?
by Zacks Equity Research
Manulife Financial (MFC) seems to be a good value pick, as it has decent revenue metrics to back up its earnings, and is seeing solid earnings estimate revisions as well.
Should Value Investors Buy Manulife Financial (MFC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Manulife Financial (MFC) Q3 Earnings Rise on Business Growth
by Zacks Equity Research
Solid segmental performances across Asia, United States plus Global Wealth and Asset Management as well as higher APE sales and AUM drive Manulife Financial's (MFC) Q3 performance.
Why Manulife (MFC) Might Surprise This Earnings Season
by Zacks Equity Research
Manulife (MFC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.